FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stanley Wolf

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Paresh Thakker; Stanley Wolf; Andrew Wood; James D Clark; Mary Collins; Samuel J Goldman; Vijay K Kuchroo; Michael W Leach; Katherine L Lee; Suzana Marusic; John C McKew; Nancy L Stedman; Mina Hassan-Zahraee
Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
Suzana Marusic; Paresh Thakker; Jeffrey W Pelker; Nancy L Stedman; Katherine L Lee; John C McKew; Lixin Han; Xin Xu; Stanley Wolf; Adam J Borey; Junqing Cui; Marina W H Shen; Fran Donahue; Mina Hassan-Zahraee; Michael W Leach; Takao Shimizu; James D Clark
Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.
Chyi-Song Hsieh; Steven E Macatonia; Catherine S Tripp; Stanley Wolf; Anne O'Garra; Kenneth M Murphy
Pillars article: development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. 1993. Science 260(5107): 547-549.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stanley Wolf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Paresh Thakker; Stanley Wolf; Andrew Wood; James D Clark; Mary Collins; Samuel J Goldman; Vijay K Kuchroo; Michael W Leach; Katherine L Lee; Suzana Marusic; John C McKew; Nancy L Stedman; Mina Hassan-Zahraee
Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(4):1986-97.
2008: Suzana Marusic; Paresh Thakker; Jeffrey W Pelker; Nancy L Stedman; Katherine L Lee; John C McKew; Lixin Han; Xin Xu; Stanley Wolf; Adam J Borey; Junqing Cui; Marina W H Shen; Fran Donahue; Mina Hassan-Zahraee; Michael W Leach; Takao Shimizu; James D Clark
Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.
Journal of neuroimmunology 2008;204(1-2):29-37.
2008: Chyi-Song Hsieh; Steven E Macatonia; Catherine S Tripp; Stanley Wolf; Anne O'Garra; Kenneth M Murphy
Pillars article: development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. 1993. Science 260(5107): 547-549.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(7):4437-9.
2008: Xiaoke Yang; Julie Lee; Jonathan Brooks; James Wilhelm; David Myszka; Marion T Kasaian; Samuel Goldman; Stanley Wolf; Lori Fitz
Binding characterization of the interleukin-13 signaling complex and development of a ternary time-resolved fluorescence resonance energy transfer assay.
Analytical biochemistry 2008;376(2):206-12.
2003: TD Nguyen; G Bigaignon; Dominique Markine-Goriaynoff; H Heremans; T N Nguyen; Guy Warnier; M Delmee; M Warny; Stanley Wolf; Catherine Uyttenhove; Jacques Van Snick; Jean-Paul Coutelier
Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon.
Journal of medical microbiology 2003;52(Pt 10):869-76.
2001: H Zhou; M Sequeira; M E Goad; Jamie Erickson; A Wong; E Clark; Kyriaki Dunussi-Joannopoulos; R C Li; S Friedrich; L L Hayes; Stanley Wolf
Efficacy and mechanisms of action of rmB7.2-Ig as an antitumor agent in combination with Adriamycin and Cytoxan chemotherapy.
Clinical immunology (Orlando, Fla.) 2001;101(3):303-14.
2001: Adriana A Byrnes; X Ma; PJ Cuomo; K Park; L Wahl; Stanley Wolf; H Zhou; G Trinchieri; Christopher L Karp
Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunity.
European journal of immunology 2001;31(7):2026-34.
1999: Lisa R Schopf; JL Bliss; LM Lavigne; CL Chung; Stanley Wolf; Joseph P Sypek
Interleukin-12 is capable of generating an antigen-specific Th1-type response in the presence of an ongoing infection-driven Th2-type response.
Infection and immunity 1999;67(5):2166-71.
1998: TD Nguyen; G Bigaignon; J Van Broeck; M Vercammen; T N Nguyen; M Delmee; M Turneer; Stanley Wolf; Jean-Paul Coutelier
Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses.
Infection and immunity 1998;66(6):2991-5.
1996: L Li; D Young; Stanley Wolf; YS Choi
Interleukin-12 stimulates B cell growth by inducing IFN-gamma.
Cellular immunology 1996;168(2):133-40.
1996: JL Bliss; V Van Cleave; K Murray; A Wiencis; M Ketchum; R Maylor; T Haire; C Resmini; A K Abbas; Stanley Wolf
IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):887-94.
1996: Xiaojing Ma; J M Chow; G Gri; G Carra; F Gerosa; Stanley Wolf; R Dzialo; G Trinchieri
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.
The Journal of experimental medicine 1996;183(1):147-57.
1995: Stanley Wolf; JL Bliss; K Stokes; Joseph P Sypek
Activity of IL12 as adjuvant in promoting Th1 and Th2 recall responses.
Research in immunology 1995;146(7-8):486-9.
1995: Mary M Stevenson; M F Tam; Stanley Wolf; A Sher
IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(5):2545-56.
1995: David R Milich; Stanley Wolf; J L Hughes; J E Jones
Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(15):6847-51.
1995: Jian-Ping Zou; N Yamamoto; T Fujii; H Takenaka; M Kobayashi; S H Herrmann; Stanley Wolf; Hiromi Fujiwara; Toshiyuki Hamaoka
Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
International immunology 1995;7(7):1135-45.
1995: Jason Marshall; H Secrist; Rosemarie H Dekruyff; Stanley Wolf; Dale T Umetsu
IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(1):111-7.
1995: Rosemarie H Dekruyff; Y Fang; Stanley Wolf; Dale T Umetsu
IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T cells through an effect on antigen-presenting cells.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(6):2578-87.
1995: Jean-Paul Coutelier; J Van Broeck; Stanley Wolf
Interleukin-12 gene expression after viral infection in the mouse.
Journal of virology 1995;69(3):1955-8.
1995: I Pappo; H Tahara; P D Robbins; M K Gately; Stanley Wolf; A Barnea; Michael T Lotze
Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy.
The Journal of surgical research 1995;58(2):218-26.
1995: Alain H Rook; M Kubin; M Cassin; Eric Vonderheid; BR Vowels; Jonathan T Wolfe; Stanley Wolf; A Singh; G Trinchieri; Stuart R Lessin
IL-12 reverses cytokine and immune abnormalities in Sezary syndrome.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(3):1491-8.
1994: Mario Clerici; A Sarin; R L Coffman; T A Wynn; S P Blatt; Craig W Hendrix; Stanley Wolf; Gene M Shearer; Pierre A Henkart
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(25):11811-5.
1994: Luigina Romani; Antonella Mencacci; L Tonnetti; Roberta Spaccapelo; Elio Cenci; Paolo Puccetti; Stanley Wolf; Francesco Bistoni
IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(11):5167-75.
1994: L Zitvogel; Hideaki Tahara; Q Cai; Walter J Storkus; G Muller; Stanley Wolf; M Gately; Paul D Robbins; Michael T Lotze
Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.
Human gene therapy 1994;5(12):1493-506.
1994: Peter Allan Sieling; X H Wang; M K Gately; J L Oliveros; T McHugh; Peter F Barnes; Stanley Wolf; L Golkar; M Yamamura; Y Yogi
IL-12 regulates T helper type 1 cytokine responses in human infectious disease.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(8):3639-47.
1994: C L Nastala; Howard D Edington; T G McKinney; Hideaki Tahara; M A Nalesnik; M J Brunda; M K Gately; Stanley Wolf; R D Schreiber; Walter J Storkus
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(4):1697-706.
1994: M Zhang; M K Gately; E Wang; J Gong; Stanley Wolf; S Lu; Robert L Modlin; Peter F Barnes
Interleukin 12 at the site of disease in tuberculosis.
The Journal of clinical investigation 1994;93(4):1733-9.
1994: Stanley Wolf; D Sieburth; Joseph P Sypek
Interleukin 12: a key modulator of immune function.
Stem cells (Dayton, Ohio) 1994;12(2):154-68.
1994: A J McKnight; G J Zimmer; I Fogelman; Stanley Wolf; Abul K Abbas
Effects of IL-12 on helper T cell-dependent immune responses in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2172-9.
1994: J S Orange; Stanley Wolf; Christine A Biron
Effects of IL-12 on the response and susceptibility to experimental viral infections.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(3):1253-64.
1994: Hideaki Tahara; H J Zeh; Walter J Storkus; I Pappo; simon simon watkins; U Gubler; Stanley Wolf; Paul D Robbins; Michael T Lotze
Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
Cancer research 1994;54(1):182-9.
1993: Mario Clerici; D R Lucey; Jay A Berzofsky; Ligia A Pinto; T A Wynn; S P Blatt; Matthew J Dolan; Craig W Hendrix; Stanley Wolf; Gene M Shearer
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Science (New York, N.Y.) 1993;262(5140):1721-4.
1993: M J Brunda; L Luistro; R R Warrier; R B Wright; B R Hubbard; M Murphy; Stanley Wolf; MK Gately
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
The Journal of experimental medicine 1993;178(4):1223-30.
1993: T W Salcedo; Livio Azzoni; Stanley Wolf; Bice Perussia
Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(5):2511-20.
1993: Jihed Chehimi; Nicholas M Valiante; A D'Andrea; M Rengaraju; Z Rosado; M Kobayashi; Bice Perussia; Stanley Wolf; Stuart E Starr; G Trinchieri
Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
European journal of immunology 1993;23(8):1826-30.
1993: Joseph P Sypek; C L Chung; S E Mayor; J M Subramanyam; Samuel J Goldman; D S Sieburth; Stanley Wolf; R G Schaub
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
The Journal of experimental medicine 1993;177(6):1797-802.
1993: C S Hsieh; S E Macatonia; C S Tripp; Stanley Wolf; Anne O'Garra; Kenneth M Murphy
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
Science (New York, N.Y.) 1993;260(5107):547-9.
1993: C S Tripp; Stanley Wolf; Emil R Unanue
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(8):3725-9.
1992: Bice Perussia; S H Chan; A D'Andrea; K Tsuji; D Santoli; M Pospisil; D Young; Stanley Wolf; G Trinchieri
Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(11):3495-502.
1992: D Sieburth; Ethylin Jabs; J A Warrington; X Li; J Lasota; S LaForgia; K Kelleher; Kay Huebner; J J Wasmuth; Stanley Wolf
Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5.
Genomics 1992;14(1):59-62.
1992: M J Robertson; Robert J Soiffer; Stanley Wolf; T J Manley; C Donahue; D Young; S H Herrmann; Jerome Ritz
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
The Journal of experimental medicine 1992;175(3):779-88.
1992: D M Merberg; Stanley Wolf; S C Clark
Sequence similarity between NKSF and the IL-6/G-CSF family.
Immunology today 1992;13(2):77-8.
1991: Stanley Wolf; P A Temple; M Kobayashi; D Young; M Dicig; L Lowe; R Dzialo; Lori Fitz; C Ferenz; R M Hewick
Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(9):3074-81.
1991: S H Chan; B Perussia; J W Gupta; M Kobayashi; M Pospísil; H A Young; Stanley Wolf; D Young; S C Clark; G Trinchieri
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
The Journal of experimental medicine 1991;173(4):869-79.
1989: M Collins; Stanley Wolf; L L Haines; L Mitsock
The use of denaturing gradient gel electrophoresis to screen for DNA sequence polymorphisms in the human factor VIII gene.
Electrophoresis 1989;10(5-6):390-6.
1988: Y Shabo; Joseph Lotem; M Rubinstein; Michel Revel; S C Clark; Stanley Wolf; R Kamen; Leo Sachs
The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6.
Blood 1988;72(6):2070-3.
1988: Y C Yang; S Kovacic; Ron Kriz; Stanley Wolf; S C Clark; Thomas E Wellems; A Nienhuis; N Epstein
The human genes for GM-CSF and IL 3 are closely linked in tandem on chromosome 5.
Blood 1988;71(4):958-61.
1987: Stanley Wolf; L Haines; J Fisch; J N Kremsky; J P Dougherty; K Jacobs
Rapid hybridization kinetics of DNA attached to submicron latex particles.
Nucleic acids research 1987;15(7):2911-26.
1985: M Schmidt; Stanley Wolf; Barbara R Migeon
Evidence for a relationship between DNA methylation and DNA replication from studies of the 5-azacytidine-reactivated allocyclic X chromosome.
Experimental cell research 1985;158(2):301-10.
1985: Barbara R Migeon; Stanley Wolf; Joyce Axelman; D C Kaslow; M Schmidt
Incomplete X chromosome dosage compensation in chorionic villi of human placenta.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(10):3390-4.
1985: Barbara R Migeon; G G Johnson; Stanley Wolf; Joyce Axelman; M Schmidt
Hyperexpression of HPRT induced by 5-azacytidine in mouse-human hybrid reactivants.
American journal of human genetics 1985;37(3):608-11.